Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Delphine Delcroix-Genête"'
Autor:
Gilles Riveau, Anne-Marie Schacht, Jean-Pierre Dompnier, Dominique Deplanque, Modou Seck, Nawal Waucquier, Simon Senghor, Delphine Delcroix-Genete, Emmanuel Hermann, Noureddine Idris-Khodja, Claire Levy-Marchal, Monique Capron, André Capron
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 12, p e0006968 (2018)
BackgroundUrinary schistosomiasis, the result of infection by Schistosoma haematobium (Sh), remains a major global health concern. A schistosome vaccine could represent a breakthrough in schistosomiasis control strategies, which are presently based o
Externí odkaz:
https://doaj.org/article/6cc91bc0abd0450a9e487d449f465718
Autor:
Marina Caillet, Katy Janvier, Annegret Pelchen-Matthews, Delphine Delcroix-Genête, Grégory Camus, Mark Marsh, Clarisse Berlioz-Torrent
Publikováno v:
PLoS Pathogens, Vol 7, Iss 11, p e1002347 (2011)
Retroviruses take advantage of cellular trafficking machineries to assemble and release new infectious particles. Rab proteins regulate specific steps in intracellular membrane trafficking by recruiting tethering, docking and fusion factors, as well
Externí odkaz:
https://doaj.org/article/8738941ec72f4937a4ea43ba60a0b497
Autor:
Katy Janvier, Anne Hosmalin, Guillaume Hoeffel, Clarisse Berlioz-Torrent, Sandra López-Vergès, Hélène Bauby, Fabrizio Mammano, Delphine Delcroix-Genête
Publikováno v:
Retrovirology
Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts, Sep 2009, Montpellier, France. pp.P8, ⟨10.1186/1742-4690-6-S2-P8⟩
Traffic
Traffic, Wiley, 2010, 11 (4), pp.455-67. ⟨10.1111/j.1600-0854.2010.01036.x⟩
Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts, Sep 2009, Montpellier, France. BioMed Central, 6 (Suppl 2), pp.P8, 2009, Retrovirology. 〈10.1186/1742-4690-6-S2-P8〉
Retrovirology, Vol 6, Iss Suppl 2, p P8 (2009)
Traffic, Wiley, 2010, 11 (4), pp.455-67. 〈10.1111/j.1600-0854.2010.01036.x〉
Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts, Sep 2009, Montpellier, France. pp.P8, ⟨10.1186/1742-4690-6-S2-P8⟩
Traffic
Traffic, Wiley, 2010, 11 (4), pp.455-67. ⟨10.1111/j.1600-0854.2010.01036.x⟩
Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts, Sep 2009, Montpellier, France. BioMed Central, 6 (Suppl 2), pp.P8, 2009, Retrovirology. 〈10.1186/1742-4690-6-S2-P8〉
Retrovirology, Vol 6, Iss Suppl 2, p P8 (2009)
Traffic, Wiley, 2010, 11 (4), pp.455-67. 〈10.1111/j.1600-0854.2010.01036.x〉
Macrophages are, along with T CD4+lymphocytes, the major targets of HIV-1 infection and play a key role in viral pathogenesis as a significant reservoir. Identification of the cellular cofactors involved in the production of infectious HIV-1 from mac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7046c379202bce7dc78c79afb01ad45d
https://doi.org/10.1111/j.1600-0854.2010.01036.x
https://doi.org/10.1111/j.1600-0854.2010.01036.x
Autor:
Marie-Gaëlle Roger, Delphine Delcroix-Genête, Cécile Rousseau, Sébastien Nisole, Uriel Hazan, Phenix-Lan Quan
Publikováno v:
Retrovirology
Retrovirology, BioMed Central, 2006, 3, pp.16. 〈10.1186/1742-4690-3-16〉
Retrovirology, Vol 3, Iss 1, p 16 (2006)
Retrovirology, 2006, 3, pp.16. ⟨10.1186/1742-4690-3-16⟩
Retrovirology, BioMed Central, 2006, 3, pp.16. ⟨10.1186/1742-4690-3-16⟩
Retrovirology, BioMed Central, 2006, 3, pp.16. 〈10.1186/1742-4690-3-16〉
Retrovirology, Vol 3, Iss 1, p 16 (2006)
Retrovirology, 2006, 3, pp.16. ⟨10.1186/1742-4690-3-16⟩
Retrovirology, BioMed Central, 2006, 3, pp.16. ⟨10.1186/1742-4690-3-16⟩
Background As it is the very first step of the HIV replication cycle, HIV entry represents an attractive target for the development of new antiviral drugs. In this context, fusion inhibitors are the third class of anti-HIV drugs to be used for treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4cf0039109f13f743b9d335cee8ff7
https://doi.org/10.1186/1742-4690-3-16
https://doi.org/10.1186/1742-4690-3-16
Publikováno v:
Retrovirology, Vol 2, Iss 1, p 73 (2005)
Retrovirology
Retrovirology, 2005, 2, pp.73. ⟨10.1186/1742-4690-2-73⟩
Retrovirology, BioMed Central, 2005, 2, pp.73. 〈10.1186/1742-4690-2-73〉
Retrovirology, BioMed Central, 2005, 2, pp.73. ⟨10.1186/1742-4690-2-73⟩
Retrovirology
Retrovirology, 2005, 2, pp.73. ⟨10.1186/1742-4690-2-73⟩
Retrovirology, BioMed Central, 2005, 2, pp.73. 〈10.1186/1742-4690-2-73〉
Retrovirology, BioMed Central, 2005, 2, pp.73. ⟨10.1186/1742-4690-2-73⟩
BackgroundThe persistence of latent HIV-1 reservoirs is the principal barrier preventing the eradication of HIV-1 infection in patients by current antiretroviral therapy. It is thus crucial to understand the molecular mechanisms involved in the estab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3f72ed1651d19573a618d4a6e1ef623
https://doi.org/10.1186/1742-4690-2-73
https://doi.org/10.1186/1742-4690-2-73